Inventor
KALLA RAO
US22 patents
⚠️ This page may combine multiple inventors who share the name “KALLA RAO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CV THERAPEUTICS INC
11 patentsUS6977300B2Dec 20, 2005
A2B adenosine receptor antagonists
CV THERAPEUTICS INC69 citations98
US6825349B2Nov 30, 2004
A2B adenosine receptor antagonists
CV THERAPEUTICS INC95 citations98
US7317017B2Jan 8, 2008
A2B adenosine receptor antagonists
CV THERAPEUTICS INC22 citations92
US7304070B2Dec 4, 2007
A2B adenosine receptor antagonists
CV THERAPEUTICS INC23 citations92
US7125993B2Oct 24, 2006
A2B adenosine receptor antagonists
CV THERAPEUTICS INC37 citations92
US7105665B2Sep 12, 2006
A2B adenosine receptor antagonists
CV THERAPEUTICS INC12 citations84
US7521554B2Apr 21, 2009
A2B adenosine receptor antagonists
CV THERAPEUTICS INC7 citations73
US7514417B2Apr 7, 2009
A1 adenosine receptor agonists
CV THERAPEUTICS INC2 citations63
US7381714B2Jun 3, 2008
A1 adenosine receptor agonists
CV THERAPEUTICS INC4 citations63
US7449473B2Nov 11, 2008
Substituted pyrrolo[3,2-d]pyrimidin-2,4-diones as A2b adenosine receptor antagonists
CV THERAPEUTICS INC5 citations62
US7022710B2Apr 4, 2006
A1 adenosine receptor antagonists
CV THERAPEUTICS INC1 citations51
GILEAD PALO ALTO INC
4 patentsUS7741331B2Jun 22, 2010
A2B adenosine receptor antagonists
GILEAD PALO ALTO INC16 citations92
US7625881B2Dec 1, 2009
Prodrugs of A2B adenosine receptor antagonists
GILEAD PALO ALTO INC31 citations92
US7795269B2Sep 14, 2010
A2B adenosine receptor antagonists
GILEAD PALO ALTO INC8 citations84
US7776868B2Aug 17, 2010
Substituted bicyclic and tricyclic thieno[2,3-d]pyrimidines as A2A adenosine receptor antagonists
GILEAD PALO ALTO INC0 citations52